Literature DB >> 1952589

Nonsyndromal profound genetic deafness in childhood.

C W Cremers1, H A Marres, P M van Rijn.   

Abstract

About one-half of children with profound deafness have an autosomal recessive or autosomal dominant inherited type of deafness. The X-linked inherited types of deafness are rare. About one out of three profoundly deaf children has an autosomal recessive form of inherited deafness. At sometime during their life a syndromal diagnosis can be made in one out of four cases with an autosomal recessive form of deafness. Therefore in about 25% of all the children with profound deafness, a nonsyndromal autosomal recessive type of genetic deafness will be involved. It is still not clear how many different genes are responsible for this. The more severe the deafness in a child, the greater the chance that an autosomal recessive etiology is involved. The autosomal dominant inherited types of deafness are significantly more frequent in cases where the hearing loss in the best ear is less than 80-90 db. About one-half of the autosomal dominant inherited cases show a classical syndromal type of deafness based on clinical features. In the other half, some audiometrically recognizable types of deafness can be diagnosed after an autosomal dominant pattern of inheritance has been established. Additional genetic knowledge based on gene-linkage studies is needed to provide better tools for the more accurate diagnosis of genetic etiology in a profoundly deaf child. Adequate pedigrees are quite rare and such pedigrees are expected to become even more scarce as a result of a diminishing ratio of consanguineous marriages. It is necessary to start gene-linkage studies in these existing pedigrees to trace the genes responsible for this nonsyndromal type of profound genetic deafness in childhood.

Entities:  

Mesh:

Year:  1991        PMID: 1952589     DOI: 10.1111/j.1749-6632.1991.tb19587.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Linkage of congenital recessive deafness (gene DFNB10) to chromosome 21q22.3.

Authors:  B Bonné-Tamir; A L DeStefano; C E Briggs; R Adair; B Franklyn; S Weiss; M Korostishevsky; M Frydman; C T Baldwin; L A Farrer
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  Identification of four novel connexin 26 mutations in non-syndromic deaf patients: genotype-phenotype analysis in moderate cases.

Authors:  Viviana Dalamón; M Florencia Wernert; Vanesa Lotersztein; Patricio O Craig; Raúl Reynoso Diamante; María E Barteik; Carlos Curet; Bibiana Paoli; Enrique Mansilla; Ana Belén Elgoyhen
Journal:  Mol Biol Rep       Date:  2013-10-25       Impact factor: 2.316

Review 3.  Genetic basis of hearing loss in Spanish, Hispanic and Latino populations.

Authors:  Rahul Mittal; Amit P Patel; Desiree Nguyen; Debbie R Pan; Vasanti M Jhaveri; Jason R Rudman; Arjuna Dharmaraja; Denise Yan; Yong Feng; Prem Chapagain; David J Lee; Susan H Blanton; Xue Zhong Liu
Journal:  Gene       Date:  2018-01-10       Impact factor: 3.688

4.  A Novel C-Terminal CIB2 (Calcium and Integrin Binding Protein 2) Mutation Associated with Non-Syndromic Hearing Loss in a Hispanic Family.

Authors:  Kunjan Patel; Arnaud P Giese; J M Grossheim; Rashmi S Hegde; Rashima S Hegde; Maria Delio; Joy Samanich; Saima Riazuddin; Gregory I Frolenkov; Jinlu Cai; Zubair M Ahmed; Bernice E Morrow
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

5.  Audiometric evaluation of carriers of the connexin 26 mutation 35delG.

Authors:  Annamaria Franzé; Antonella Caravelli; Francesca Di Leva; Elio Marciano; Gennaro Auletta; Federica D'Aulos; Claudio Saulino; Laura Esposito; Massimo Carella; Paolo Gasparini
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-14       Impact factor: 2.503

6.  Frequency of GJB2 mutations in patients with nonsyndromic hearing loss from an ethnically characterized Brazilian population.

Authors:  Felippe Felix; Marcia Gonçalves Ribeiro; Shiro Tomita; Mariano Gustavo Zalis
Journal:  Braz J Otorhinolaryngol       Date:  2017-11-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.